Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• A Novel Approach to Immunosuppression in Solid Organ Transplantation: Getting to Know JAK


This activity explores a new concept in the approach to immunosupporession in solid ogan transplantation.  Through this program, Dr. Moore identifies limitations associated with currently available maintenance immunosuppression, describes immunogenicity associated with the common cytokine receptor gamma chain and janus kinase (JAK) inhibitor mechanism of action, and discusses the efficacy and safety outcomes for tofacitnib in rheumatoid arthritis and renal transplantation.

Fee

$25.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Co-Sponsor(s)

ACCP Immunology Transplantation PRN

Requirements for CE Credit

 

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.10 CEUs (1.00 contact hours) of continuing education credit.  In order to receive 1.00 contact hours of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete the online evaluation. 

 

 

 

Objectives

  • Identity limitations associated with currently available maintenance immunosuppression
  • Describe immunogenicity associated with the common cytokine receptor gamma chain and janus kinase (JAK) inhibitor mechanism of action
  • Discuss the efficacy and safety outcomes for tofacitnib in rheumatoid arthritis and renal transplantation

Activity Number

0067-9999-15-033-H01-P

Release Date: Dec 17, 2015
Credit Expiration Date: Dec 1, 2018

CE Hours

1.00